ArticleBritish journal of cancer2024

Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma.

Kévin Louault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.